To determine the association between BAZ2A expression levels and tumor pathological stage, we evaluated BAZ2A expression in patients using CPTAC analysis and found that upregulation of BAZ2A protein expression correlated with pathological stage of clear cell carcinoma, UCEC, ovarian cancer, and colon cancer (Supplementary Fig. 1A). The gene discussed is BAZ2A; the disease is malignant colon neoplasm.